Clinical Trial Update: Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hormone suppression with or without docetaxel plus radiation therapy in high-risk prostate cancer; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-07-28